| Identification | Back Directory | [Name]
DBCO-PEG5-NHS ester | [CAS]
2144395-59-3 | [Synonyms]
4,7,10,13,16-Pentaoxa-19-azatricosanoic acid, 23-(11,12-didehydrodibenz[b,f]azocin-5(6H)-yl)-20,23-dioxo-, 2,5-dioxo-1-pyrrolidinyl ester | [Molecular Formula]
C36H43N3O11 | [MDL Number]
MFCD22380747 | [MOL File]
2144395-59-3.mol | [Molecular Weight]
693.74 |
| Chemical Properties | Back Directory | [storage temp. ]
-20°C, sealed storage, away from moisture and light | [solubility ]
Soluble in DMSO, DCM, DMF | [form ]
Oil | [color ]
Colorless to light yellow |
| Hazard Information | Back Directory | [Description]
DBCO-PEG5-NHS Ester is a DBCO-containing PEG linker containing NHS ester that can react specifically and efficiently with primary amines (e.g. the side chain of lysine residues or aminosilane-coated surfaces) at neutral or slightly basic condition to form a covalent bond. PEG5 spacer increases the water solubility of compounds in aqueous media. DBCO is commonly used for copper-free Click Chemistry reaction. | [Biological Activity]
DBCO-PEG5-NHS ester is a PROTAC linker, belonging to the PEG class and the Alkyl/ether class, for the synthesis of a series of PROTAC molecules. DBCO-PEG5-NHS ester is a cleavable ADC linker for the synthesis of antibody drug conjugates (ADCs). | [in vitro]
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker. | [target]
| Cleavable | Alkyl/ether | PEGs | |
|
| Company Name: |
Borenpharm Co., Ltd
|
| Telephone: |
027-65563561 13026317987; |
| Website: |
http://www.borenpharm.com |
|